Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | Frm | Arm | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Philadelphia - ML
PHI - ML
|
2029 | P | 7 | 11.2 | 2 | 0 | 0 | 1.000 | 1.54 | .000 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2028 | P | 11 | 74.2 | 4 | 6 | 0 | 1.000 | 1.21 | 1.041 | - | - | -0.16 |
Philadelphia - ML
PHI - ML
|
2027 | P | 31 | 216.2 | 10 | 39 | 3 | .942 | 2.04 | 1.010 | - | - | 0.79 |
Philadelphia - ML
PHI - ML
|
2026 | P | 34 | 217.0 | 15 | 42 | 0 | 1.000 | 2.36 | 1.050 | - | - | 2.23 |
Philadelphia - ML
PHI - ML
|
2025 | P | 32 | 216.1 | 5 | 35 | 1 | .976 | 1.66 | 1.061 | - | - | 2.73 |
Philadelphia - ML
PHI - ML
|
2025 | 2B | 1 | 0.2 | 0 | 0 | 0 | .000 | 0.00 | .000 | - | - | 0.00 |
Philadelphia - ML
PHI - ML
|
2024 | P | 57 | 119.1 | 4 | 25 | 0 | 1.000 | 2.19 | 1.134 | - | - | 2.89 |
Philadelphia - ML
PHI - ML
|
2023 | P | 20 | 79.2 | 6 | 7 | 0 | 1.000 | 1.47 | 1.013 | - | - | 0.52 |
Philadelphia - ML
PHI - ML
|
2022 | P | 5 | 31.2 | 3 | 8 | 0 | 1.000 | 3.13 | 1.139 | - | - | 0.37 |
Philadelphia - ML
PHI - ML
|
2021 | P | 31 | 180.1 | 9 | 36 | 2 | .957 | 2.25 | 1.018 | - | - | 0.95 |
Philadelphia - ML
PHI - ML
|
2020 | P | 23 | 116.1 | 5 | 25 | 4 | .882 | 2.32 | .933 | - | - | -1.00 |
Philadelphia - ML
PHI - ML
|
2019 | P | 6 | 32.0 | 2 | 2 | 0 | 1.000 | 1.13 | 1.523 | - | - | 0.34 |
Philadelphia - ML
PHI - ML
|
2018 | P | 32 | 203.2 | 13 | 30 | 3 | .935 | 1.90 | 1.147 | - | - | 3.62 |
Philadelphia - ML
PHI - ML
|
2017 | P | 38 | 166.0 | 9 | 26 | 1 | .972 | 1.90 | 1.051 | - | - | -0.58 |
Philadelphia - ML
PHI - ML
|
2016 | P | 42 | 94.2 | 7 | 11 | 0 | 1.000 | 1.71 | 1.023 | - | - | 0.49 |
Philadelphia - ML
PHI - ML
|
2015 | P | 39 | 41.0 | 2 | 3 | 0 | 1.000 | 1.10 | 1.023 | - | - | 0.15 |
Philadelphia - ML
PHI - ML
|
2014 | P | 5 | 1.2 | 0 | 1 | 0 | 1.000 | 5.40 | 1.038 | - | - | 0.02 |
Total | P | 413 | 1802.2 | 96 | 296 | 14 | - | - | - | - | - | 13.36 | |
Total | 2B | 1 | 0.2 | 0 | 0 | 0 | - | - | - | - | - | 0.00 |